Electra Therapeutics is pioneering a new class of precision medicines focused on Signal Regulatory Protein (SIRP)-directed therapies aimed at improving outcomes for patients with immune-mediated diseases and cancer
Electra Therapeutics is pioneering a new class of precision medicines focused on Signal Regulatory Protein (SIRP)-directed therapies aimed at improving outcomes for patients with immune-mediated diseases and cancer.
The top three firms on F4's Biotech & Life Sciences investor list.